Dataset Preview
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
The dataset generation failed because of a cast error
Error code: DatasetGenerationCastError
Exception: DatasetGenerationCastError
Message: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 13 new columns ({'GO id', 'Additional location', 'Gene name', 'Uncertain', 'Extracellular location', 'Single-cell variation intensity', 'Supported', 'Cell cycle dependency', 'Reliability', 'Enhanced', 'Approved', 'Single-cell variation spatial', 'Main location'}) and 106 missing columns ({'Antibody RRID', 'RNA single cell type specific nTPM', 'Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)', 'Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)', 'Cancer prognostics - Breast Invasive Carcinoma (TCGA)', 'RNA single nuclei brain distribution', 'Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)', 'RNA tissue distribution', 'CCD Protein', 'Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)', 'RNA tissue specific nTPM', 'RNA pig brain regional distribution', 'Subcellular main location', 'Secretome location', 'Cancer prognostics - Prostate Adenocarcinoma (TCGA)', 'UniProt evidence', 'RNA blood cell distribution', 'Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)', 'Cancer prognostics - Lung Squamous Cell Carcinoma (validation)', 'Protein class', 'NeXtProt evidence', 'Cancer prognostics - Breast Invasive Carcinoma (validation)', 'RNA cancer specificity score', 'Gene description', 'RNA mouse brain regional specificity score', 'RNA tissue cell type enrichment', 'Single cell expression cluster', 'Cancer prognostics - Lung Adenocarcinoma (validation)', 'RNA tissue specificity score', 'Gene synonym', 'RNA cancer specific FPKM', 'Brain expression cluster', 'Cancer prognostics - Liver Hepatocellular Carcinoma (validation)', 'RNA mouse brain regional specific nTPM', 'RNA single nuclei brain specificity score', 'RNA cell line specificity score', 'RNA cancer specificity', 'Blood expression cluster', 'RNA blood cell specific nTPM
...
n regional specificity score', 'Blood concentration - Conc. blood MS [pg/L]', 'Tissue expression cluster', 'Reliability (IH)', 'RNA mouse brain regional specificity', 'Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)', 'RNA pig brain regional specificity', 'Interactions', 'Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)', 'Secretome function', 'Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)', 'Position', 'Cancer prognostics - Lung Adenocarcinoma (TCGA)', 'RNA brain regional distribution', 'Cancer prognostics - Rectum Adenocarcinoma (validation)', 'RNA blood lineage specificity score', 'Cancer prognostics - Stomach Adenocarcinoma (TCGA)', 'RNA blood cell specificity', 'Subcellular additional location', 'RNA single nuclei brain specificity', 'RNA single nuclei brain specific nTPM', 'Cancer prognostics - Kidney Chromophobe (TCGA)', 'RNA cancer distribution', 'Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)', 'Cancer prognostics - Thyroid Carcinoma (TCGA)', 'Cancer prognostics - Testicular Germ Cell Tumor (TCGA)', 'Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)', 'Cancer prognostics - Colon Adenocarcinoma (validation)', 'Chromosome', 'Evidence', 'Reliability (Mouse Brain)', 'RNA single cell type distribution', 'RNA pig brain regional specificity score', 'Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)', 'RNA single cell type specificity', 'HPA evidence'}).
This happened while the csv dataset builder was generating data using
hf://datasets/Scripta/HPA/subcellular_location.tsv (at revision b3b061ca16f6c58c7fdaae34b74a1bb664ec41f4)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)
Traceback: Traceback (most recent call last):
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1870, in _prepare_split_single
writer.write_table(table)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/arrow_writer.py", line 622, in write_table
pa_table = table_cast(pa_table, self._schema)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/table.py", line 2292, in table_cast
return cast_table_to_schema(table, schema)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/table.py", line 2240, in cast_table_to_schema
raise CastError(
datasets.table.CastError: Couldn't cast
Gene: string
Gene name: string
Reliability: string
Main location: string
Additional location: string
Extracellular location: string
Enhanced: string
Supported: string
Approved: string
Uncertain: string
Single-cell variation intensity: string
Single-cell variation spatial: string
Cell cycle dependency: string
GO id: string
-- schema metadata --
pandas: '{"index_columns": [{"kind": "range", "name": null, "start": 0, "' + 2059
to
{'Gene': Value(dtype='string', id=None), 'Gene synonym': Value(dtype='string', id=None), 'Ensembl': Value(dtype='string', id=None), 'Gene description': Value(dtype='string', id=None), 'Uniprot': Value(dtype='string', id=None), 'Chromosome': Value(dtype='string', id=None), 'Position': Value(dtype='string', id=None), 'Protein class': Value(dtype='string', id=None), 'Biological process': Value(dtype='string', id=None), 'Molecular function': Value(dtype='string', id=None), 'Disease involvement': Value(dtype='string', id=None), 'Evidence': Value(dtype='string', id=None), 'HPA evidence': Value(dtype='string', id=None), 'UniProt evidence': Value(dtype='string', id=None), 'NeXtProt evidence': Value(dtype='string', id=None), 'RNA tissue specificity': Value(dtype='string', id=None), 'RNA tissue distribution': Value(dtype='string', id=None), 'RNA tissue specificity score': Value(dtype='float64', id=None), 'RNA tissue specific nTPM': Value(dtype='string', id=None), 'RNA single cell type specificity': Value(dtype='string', id=None), 'RNA single cell type distribution': Value(dtype='string', id=None), 'RNA single cell type specificity score': Value(dtype='float64', id=None), 'RNA single cell type specific nTPM': Value(dtype='string', id=None), 'RNA single nuclei brain specificity': Value(dtype='string', id=None), 'RNA single nuclei brain distribution': Value(dtype='string', id=None), 'RNA single nuclei brain specificity score': Value(dtype='float64', id=None), 'RNA single nuclei brain spec
...
noma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Lung Adenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Lung Adenocarcinoma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Lung Squamous Cell Carcinoma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Pancreatic Adenocarcinoma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Prostate Adenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Rectum Adenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Rectum Adenocarcinoma (validation)': Value(dtype='string', id=None), 'Cancer prognostics - Skin Cuteneous Melanoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Stomach Adenocarcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Testicular Germ Cell Tumor (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Thyroid Carcinoma (TCGA)': Value(dtype='string', id=None), 'Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)': Value(dtype='string', id=None)}
because column names don't match
During handling of the above exception, another exception occurred:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1420, in compute_config_parquet_and_info_response
parquet_operations = convert_to_parquet(builder)
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1052, in convert_to_parquet
builder.download_and_prepare(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 924, in download_and_prepare
self._download_and_prepare(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1000, in _download_and_prepare
self._prepare_split(split_generator, **prepare_split_kwargs)
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1741, in _prepare_split
for job_id, done, content in self._prepare_split_single(
File "/src/services/worker/.venv/lib/python3.9/site-packages/datasets/builder.py", line 1872, in _prepare_split_single
raise DatasetGenerationCastError.from_cast_error(
datasets.exceptions.DatasetGenerationCastError: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 13 new columns ({'GO id', 'Additional location', 'Gene name', 'Uncertain', 'Extracellular location', 'Single-cell variation intensity', 'Supported', 'Cell cycle dependency', 'Reliability', 'Enhanced', 'Approved', 'Single-cell variation spatial', 'Main location'}) and 106 missing columns ({'Antibody RRID', 'RNA single cell type specific nTPM', 'Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)', 'Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)', 'Cancer prognostics - Breast Invasive Carcinoma (TCGA)', 'RNA single nuclei brain distribution', 'Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)', 'RNA tissue distribution', 'CCD Protein', 'Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)', 'RNA tissue specific nTPM', 'RNA pig brain regional distribution', 'Subcellular main location', 'Secretome location', 'Cancer prognostics - Prostate Adenocarcinoma (TCGA)', 'UniProt evidence', 'RNA blood cell distribution', 'Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)', 'Cancer prognostics - Lung Squamous Cell Carcinoma (validation)', 'Protein class', 'NeXtProt evidence', 'Cancer prognostics - Breast Invasive Carcinoma (validation)', 'RNA cancer specificity score', 'Gene description', 'RNA mouse brain regional specificity score', 'RNA tissue cell type enrichment', 'Single cell expression cluster', 'Cancer prognostics - Lung Adenocarcinoma (validation)', 'RNA tissue specificity score', 'Gene synonym', 'RNA cancer specific FPKM', 'Brain expression cluster', 'Cancer prognostics - Liver Hepatocellular Carcinoma (validation)', 'RNA mouse brain regional specific nTPM', 'RNA single nuclei brain specificity score', 'RNA cell line specificity score', 'RNA cancer specificity', 'Blood expression cluster', 'RNA blood cell specific nTPM
...
n regional specificity score', 'Blood concentration - Conc. blood MS [pg/L]', 'Tissue expression cluster', 'Reliability (IH)', 'RNA mouse brain regional specificity', 'Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)', 'RNA pig brain regional specificity', 'Interactions', 'Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)', 'Secretome function', 'Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)', 'Position', 'Cancer prognostics - Lung Adenocarcinoma (TCGA)', 'RNA brain regional distribution', 'Cancer prognostics - Rectum Adenocarcinoma (validation)', 'RNA blood lineage specificity score', 'Cancer prognostics - Stomach Adenocarcinoma (TCGA)', 'RNA blood cell specificity', 'Subcellular additional location', 'RNA single nuclei brain specificity', 'RNA single nuclei brain specific nTPM', 'Cancer prognostics - Kidney Chromophobe (TCGA)', 'RNA cancer distribution', 'Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)', 'Cancer prognostics - Thyroid Carcinoma (TCGA)', 'Cancer prognostics - Testicular Germ Cell Tumor (TCGA)', 'Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)', 'Cancer prognostics - Colon Adenocarcinoma (validation)', 'Chromosome', 'Evidence', 'Reliability (Mouse Brain)', 'RNA single cell type distribution', 'RNA pig brain regional specificity score', 'Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)', 'RNA single cell type specificity', 'HPA evidence'}).
This happened while the csv dataset builder was generating data using
hf://datasets/Scripta/HPA/subcellular_location.tsv (at revision b3b061ca16f6c58c7fdaae34b74a1bb664ec41f4)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
Gene
string | Gene synonym
string | Ensembl
string | Gene description
string | Uniprot
string | Chromosome
string | Position
string | Protein class
string | Biological process
null | Molecular function
string | Disease involvement
string | Evidence
string | HPA evidence
string | UniProt evidence
string | NeXtProt evidence
string | RNA tissue specificity
string | RNA tissue distribution
string | RNA tissue specificity score
null | RNA tissue specific nTPM
string | RNA single cell type specificity
string | RNA single cell type distribution
string | RNA single cell type specificity score
float64 | RNA single cell type specific nTPM
string | RNA single nuclei brain specificity
string | RNA single nuclei brain distribution
string | RNA single nuclei brain specificity score
null | RNA single nuclei brain specific nTPM
string | RNA cancer specificity
string | RNA cancer distribution
string | RNA cancer specificity score
null | RNA cancer specific FPKM
null | RNA brain regional specificity
string | RNA brain regional distribution
string | RNA brain regional specificity score
null | RNA brain regional specific nTPM
null | RNA blood cell specificity
string | RNA blood cell distribution
string | RNA blood cell specificity score
null | RNA blood cell specific nTPM
string | RNA blood lineage specificity
string | RNA blood lineage distribution
string | RNA blood lineage specificity score
float64 | RNA blood lineage specific nTPM
string | RNA cell line specificity
string | RNA cell line distribution
string | RNA cell line specificity score
float64 | RNA cell line specific nTPM
string | RNA tissue cell type enrichment
string | RNA mouse brain regional specificity
string | RNA mouse brain regional distribution
string | RNA mouse brain regional specificity score
null | RNA mouse brain regional specific nTPM
null | RNA pig brain regional specificity
string | RNA pig brain regional distribution
string | RNA pig brain regional specificity score
null | RNA pig brain regional specific nTPM
null | Antibody
string | Reliability (IH)
string | Reliability (Mouse Brain)
null | Reliability (IF)
string | Subcellular location
string | Secretome location
null | Secretome function
null | CCD Protein
null | CCD Transcript
null | Blood concentration - Conc. blood IM [pg/L]
null | Blood concentration - Conc. blood MS [pg/L]
null | Blood expression cluster
string | Tissue expression cluster
string | Brain expression cluster
string | Cell line expression cluster
string | Single cell expression cluster
string | Interactions
float64 | Subcellular main location
string | Subcellular additional location
string | Antibody RRID
string | Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)
string | Cancer prognostics - Breast Invasive Carcinoma (TCGA)
string | Cancer prognostics - Breast Invasive Carcinoma (validation)
string | Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)
string | Cancer prognostics - Colon Adenocarcinoma (TCGA)
string | Cancer prognostics - Colon Adenocarcinoma (validation)
string | Cancer prognostics - Glioblastoma Multiforme (TCGA)
string | Cancer prognostics - Glioblastoma Multiforme (validation)
string | Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)
string | Cancer prognostics - Kidney Chromophobe (TCGA)
string | Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)
string | Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)
string | Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)
string | Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)
string | Cancer prognostics - Liver Hepatocellular Carcinoma (validation)
string | Cancer prognostics - Lung Adenocarcinoma (TCGA)
string | Cancer prognostics - Lung Adenocarcinoma (validation)
string | Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)
string | Cancer prognostics - Lung Squamous Cell Carcinoma (validation)
string | Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)
string | Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)
string | Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)
string | Cancer prognostics - Pancreatic Adenocarcinoma (validation)
string | Cancer prognostics - Prostate Adenocarcinoma (TCGA)
string | Cancer prognostics - Rectum Adenocarcinoma (TCGA)
string | Cancer prognostics - Rectum Adenocarcinoma (validation)
string | Cancer prognostics - Skin Cuteneous Melanoma (TCGA)
string | Cancer prognostics - Stomach Adenocarcinoma (TCGA)
string | Cancer prognostics - Testicular Germ Cell Tumor (TCGA)
string | Cancer prognostics - Thyroid Carcinoma (TCGA)
string | Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TSPAN6
|
T245, TM4SF6, TSPAN-6
|
ENSG00000000003
|
Tetraspanin 6
|
O43657
|
X
|
100627108-100639991
|
Predicted membrane proteins
| null | null | null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in many
| null | null |
Cell type enriched
|
Detected in many
| 6
|
Late spermatids: 1752.2
|
Cell type enhanced
|
Detected in many
| null |
astrocyte: 32.6;ependymal cell: 58.3
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Immune cell enhanced
|
Detected in some
| null |
naive CD4 T-cell: 2.1
|
Lineage enriched
|
Detected in single
| 7
|
T-cells: 2.1
|
Low cancer specificity
|
Detected in many
| null | null |
Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Testis - Late spermatids, Thyroid gland - Thyroid glandular cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA004109
|
Approved
| null |
Approved
|
Nucleoli fibrillar center,Cell Junctions,Cytosol
| null | null | null | null | null | null |
Cluster 43: Non-specific - Transcription & Translation
|
Cluster 8: Ciliated cells - Cilium organization
|
Cluster 3: Choroid plexus - Cilium
|
Cluster 53: Squamous epithelial cells - Keratinization
|
Cluster 36: Late spermatids - Unknown function
| 2
|
Cell Junctions, Cytosol
|
Nucleoli fibrillar center
|
HPA004109: AB_1080301
|
unprognostic (1.57e-1)
|
unprognostic (2.05e-1)
|
unprognostic (1.71e-1)
|
unprognostic (3.61e-1)
|
unprognostic (3.77e-2)
|
unprognostic (1.13e-2)
|
unprognostic (4.18e-2)
|
unprognostic (1.93e-1)
|
unprognostic (2.39e-4)
|
unprognostic (4.52e-1)
|
unprognostic (4.92e-6)
|
unprognostic (3.04e-2)
|
unprognostic (1.29e-2)
|
unprognostic (2.25e-1)
|
unprognostic (1.39e-2)
|
unprognostic (6.76e-2)
|
unprognostic (6.58e-3)
|
unprognostic (3.61e-2)
|
unprognostic (1.12e-1)
|
unprognostic (4.14e-2)
|
unprognostic (2.25e-1)
|
unprognostic (7.49e-5)
|
unprognostic (1.11e-1)
|
unprognostic (3.30e-2)
|
unprognostic (3.36e-3)
|
unprognostic (4.23e-3)
|
unprognostic (1.89e-2)
|
unprognostic (7.95e-2)
|
unprognostic (2.01e-1)
|
unprognostic (4.60e-2)
|
unprognostic (1.59e-1)
|
TNMD
|
BRICD4, ChM1L, myodulin, TEM, tendin
|
ENSG00000000005
|
Tenomodulin
|
Q9H2S6
|
X
|
100584936-100599885
|
Predicted membrane proteins
| null | null | null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in some
| null |
adipose tissue: 20.4;breast: 12.5;seminal vesicle: 25.2
|
Cell type enriched
|
Detected in some
| 6
|
Adipocytes: 72.2
|
Cell type enhanced
|
Detected in single
| null |
choroid plexus epithelial cell: 2.3
|
Low cancer specificity
|
Detected in some
| null | null |
Low region specificity
|
Detected in some
| null | null |
Not detected in immune cells
|
Not detected
| null | null |
Not detected
|
Not detected
| null | null |
Group enriched
|
Detected in some
| 5
|
testis cancer: 1.1;Uterine cancer: 1.3
|
Skeletal muscle - Fibroblasts
|
Low region specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in many
| null | null |
HPA034961, HPA055634
|
Uncertain
| null | null | null | null | null | null | null | null | null | null |
Cluster 7: Adipose tissue - Mixed function
|
Cluster 36: Choroid plexus - Mixed function
|
Cluster 34: Testis cancer - Unknown function
|
Cluster 41: Adipocytes & Endothelial cells - Mixed function
| 1
| null | null |
HPA034961: AB_10670285, HPA055634: AB_2682868
| null | null |
unprognostic (2.09e-1)
| null |
unprognostic (1.68e-1)
| null |
unprognostic (6.13e-3)
| null | null | null |
unprognostic (1.21e-3)
| null | null | null | null | null | null | null | null | null | null | null | null | null |
unprognostic (2.21e-3)
| null | null | null |
unprognostic (1.55e-1)
| null | null |
DPM1
|
CDGIE, MPDS
|
ENSG00000000419
|
Dolichyl-phosphate mannosyltransferase subunit 1, catalytic
|
O60762
|
20
|
50934867-50959140
|
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
| null |
Glycosyltransferase, Transferase
|
Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy
|
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Basal respiratory cells: 234.7;Syncytiotrophoblasts: 265.5
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Adrenal gland - Adrenal cortex cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA051818
|
Approved
| null | null | null | null | null | null | null | null | null |
Cluster 33: Non-specific - ATP binding
|
Cluster 35: Non-specific - Mitochondria
|
Cluster 21: Non-specific - Metabolism
|
Cluster 62: Non-specific - Plasma proteins
|
Cluster 35: Respiratory epithelial cells - Unknown function
| 20
| null | null |
HPA051818: AB_2681624
|
unprognostic (3.18e-1)
|
unprognostic (1.74e-2)
|
unprognostic (5.36e-2)
|
unprognostic (1.68e-1)
|
unprognostic (8.80e-2)
|
unprognostic (1.49e-1)
|
unprognostic (8.45e-2)
|
unprognostic (7.06e-2)
|
unprognostic (1.03e-3)
|
unprognostic (1.66e-1)
|
unprognostic (6.27e-3)
|
unprognostic (8.16e-2)
|
unprognostic (1.76e-2)
|
unprognostic (6.46e-6)
|
unprognostic (9.90e-3)
|
unprognostic (7.73e-2)
|
unprognostic (1.72e-2)
|
unprognostic (1.22e-1)
|
unprognostic (1.91e-1)
|
unprognostic (8.15e-2)
|
unprognostic (1.26e-2)
|
unprognostic (1.64e-3)
|
unprognostic (1.57e-1)
|
unprognostic (5.86e-2)
|
unprognostic (3.10e-3)
|
unprognostic (7.21e-3)
|
unprognostic (6.73e-2)
|
unprognostic (4.37e-1)
|
unprognostic (1.73e-1)
|
unprognostic (2.03e-3)
|
unprognostic (7.59e-2)
|
SCYL3
|
PACE-1, PACE1
|
ENSG00000000457
|
SCY1 like pseudokinase 3
|
Q8IZE3
|
1
|
169849631-169894267
|
Enzymes, Predicted intracellular proteins
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Low cell type specificity
|
Detected in many
| null | null |
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Liver - Hepatocytes
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA005624, HPA072383
|
Approved
| null |
Supported
|
Golgi apparatus,Cytosol
| null | null | null | null | null | null |
Cluster 5: Non-specific - Cell proliferation
|
Cluster 1: Liver & Kidney - Metabolism
|
Cluster 50: Non-specific - Nucleic acid binding
|
Cluster 45: Non-specific - Nuclear processes
|
Cluster 55: Non-specific - Transcription
| 23
|
Golgi apparatus, Cytosol
| null |
HPA005624: AB_1854916, HPA072383:
|
unprognostic (3.28e-1)
|
unprognostic (1.44e-1)
|
unprognostic (2.23e-1)
|
unprognostic (2.20e-2)
|
unprognostic (2.36e-1)
|
unprognostic (7.49e-2)
|
unprognostic (2.41e-2)
|
unprognostic (6.83e-2)
|
unprognostic (8.54e-3)
|
unprognostic (9.70e-3)
|
unprognostic (8.33e-3)
|
unprognostic (3.64e-2)
|
unprognostic (2.88e-1)
|
unprognostic (2.00e-1)
|
unprognostic (3.30e-2)
|
unprognostic (2.57e-1)
|
unprognostic (4.61e-2)
|
unprognostic (1.54e-1)
|
unprognostic (2.06e-1)
|
unprognostic (3.95e-1)
|
unprognostic (5.87e-2)
|
unprognostic (1.31e-1)
|
unprognostic (2.85e-2)
|
unprognostic (3.03e-1)
|
unprognostic (2.05e-1)
|
unprognostic (1.12e-1)
|
unprognostic (2.20e-1)
|
unprognostic (1.57e-1)
|
unprognostic (1.70e-1)
|
unprognostic (7.81e-2)
|
unprognostic (1.02e-1)
|
C1orf112
|
FLJ10706
|
ENSG00000000460
|
Chromosome 1 open reading frame 112
|
Q9NSG2
|
1
|
169662007-169854080
|
Predicted intracellular proteins
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in many
| null |
parathyroid gland: 13.0
|
Cell type enhanced
|
Detected in many
| null |
Microglial cells: 28.6;Spermatocytes: 36.9
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in many
| null | null |
Low lineage specificity
|
Detected in many
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Skin - Mitotic cells (Skin), Testis - Spermatocytes
|
Low region specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA023778, HPA024451
|
Uncertain
| null |
Supported
|
Nucleoplasm,Nucleoli
| null | null | null | null | null | null |
Cluster 10: Non-specific - Membrane trafficking
|
Cluster 16: Non-specific - Transcription
|
Cluster 55: Non-specific - Transcription
|
Cluster 45: Non-specific - Nuclear processes
|
Cluster 58: Macrophages - Innate immune response
| 14
|
Nucleoplasm
|
Nucleoli
|
HPA023778: AB_1848665, HPA024451: AB_1848667
|
unprognostic (5.40e-3)
|
unprognostic (6.36e-2)
|
unprognostic (3.03e-2)
|
unprognostic (3.39e-2)
|
unprognostic (2.38e-3)
|
unprognostic (5.45e-2)
|
unprognostic (1.03e-1)
|
unprognostic (1.58e-2)
|
unprognostic (2.87e-2)
| null |
unprognostic (6.97e-4)
|
unprognostic (1.94e-2)
| null |
unprognostic (3.57e-3)
|
unprognostic (2.09e-2)
|
unprognostic (2.24e-4)
|
unprognostic (8.25e-5)
|
unprognostic (5.68e-2)
|
unprognostic (1.47e-1)
|
unprognostic (3.99e-1)
|
unprognostic (5.71e-1)
|
unprognostic (2.66e-5)
|
unprognostic (1.12e-2)
| null |
unprognostic (2.85e-1)
|
unprognostic (1.25e-1)
|
unprognostic (1.50e-1)
|
unprognostic (1.75e-1)
|
unprognostic (1.68e-1)
| null |
unprognostic (1.21e-2)
|
FGR
|
c-fgr, p55c-fgr, SRC2
|
ENSG00000000938
|
FGR proto-oncogene, Src family tyrosine kinase
|
P09769
|
1
|
27612064-27635185
|
Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
| null |
Kinase, Transferase, Tyrosine-protein kinase
|
Proto-oncogene
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Group enriched
|
Detected in many
| null |
bone marrow: 205.7;lung: 83.9;lymphoid tissue: 137.8
|
Cell type enhanced
|
Detected in many
| null |
Hofbauer cells: 117.4;Kupffer cells: 202.5;Langerhans cells: 79.5;Macrophages: 138.9;monocytes: 398.9;NK-cells: 135.9
|
Group enriched
|
Detected in some
| null |
endothelial cell: 71.5;leukocyte: 85.8
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Group enriched
|
Detected in some
| 16
|
Leukemia: 21.4;lymphoma: 33.4;Myeloma: 17.9
|
Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils
|
Not detected
|
Not detected
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA002024
|
Enhanced
| null |
Approved
|
Plasma membrane,Aggresome
| null | null | null | null | null | null |
Cluster 37: Monocytes & Neutrophils - Innate immune response
|
Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response
|
Cluster 47: Endothelial cells - Vasculature
|
Cluster 55: Lymphoma - Immune response
|
Cluster 29: Monocytes - Innate immune response
| 16
|
Plasma membrane
|
Aggresome
|
HPA002024: AB_1078503
|
unprognostic (2.10e-3)
|
unprognostic (1.20e-2)
|
unprognostic (1.09e-5)
|
unprognostic (4.05e-2)
|
unprognostic (2.40e-1)
|
unprognostic (5.05e-2)
|
unprognostic (9.62e-4)
|
unprognostic (1.29e-1)
|
unprognostic (7.20e-2)
|
unprognostic (1.04e-1)
|
unprognostic (1.44e-2)
|
unprognostic (2.77e-1)
|
unprognostic (5.30e-2)
|
unprognostic (1.35e-2)
|
unprognostic (2.10e-1)
|
unprognostic (2.85e-2)
|
unprognostic (2.44e-3)
|
unprognostic (8.28e-2)
|
unprognostic (4.34e-1)
|
unprognostic (2.14e-1)
|
unprognostic (9.31e-2)
|
unprognostic (1.89e-2)
|
unprognostic (5.19e-3)
|
unprognostic (3.82e-2)
|
unprognostic (5.32e-4)
|
unprognostic (9.76e-3)
|
unprognostic (1.08e-1)
|
unprognostic (9.64e-2)
|
unprognostic (5.05e-2)
|
unprognostic (2.29e-1)
|
unprognostic (9.55e-2)
|
CFH
|
ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS
|
ENSG00000000971
|
Complement factor H
|
P08603
|
1
|
196651754-196752476
|
Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
| null | null |
Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enriched
|
Detected in all
| null |
liver: 1645.3
|
Cell type enhanced
|
Detected in many
| null |
Fibroblasts: 355.9;Hepatocytes: 834.8;Leydig cells: 285.2;Mesothelial cells: 388.2;Ovarian stromal cells: 208.2
|
Group enriched
|
Detected in many
| null |
endothelial cell: 317.6;fibroblast: 269.5;pericyte: 401.5;vascular associated smooth muscle cell: 148.7
|
Cancer enriched
|
Detected in all
| null | null |
Region enhanced
|
Detected in all
| null | null |
Immune cell enhanced
|
Detected in some
| null |
MAIT T-cell: 17.6
|
Lineage enriched
|
Detected in single
| 56
|
T-cells: 17.6
|
Cancer enhanced
|
Detected in many
| null |
Gallbladder cancer: 59.2
|
Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2
| null | null | null | null | null | null | null | null |
CAB016385, CAB016769, HPA038922, HPA049176, HPA053326
|
Supported
| null |
Approved
|
Vesicles
| null | null | null | null | null | null |
Cluster 1: T-cells - Unknown function
|
Cluster 83: Liver - Metabolism
|
Cluster 42: Choroid plexus - Mitochondria
|
Cluster 71: Lymphoma - Inflammatory response
|
Cluster 53: Fibroblasts - ECM organization
| 9
|
Vesicles
| null |
CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113
|
unprognostic (3.13e-1)
|
unprognostic (2.15e-1)
|
unprognostic (4.36e-1)
|
unprognostic (1.11e-1)
|
unprognostic (3.06e-1)
|
unprognostic (8.76e-2)
|
unprognostic (2.05e-3)
|
unprognostic (3.31e-4)
|
unprognostic (2.53e-1)
|
unprognostic (1.00e-1)
|
unprognostic (3.90e-3)
|
unprognostic (2.61e-2)
|
unprognostic (1.18e-1)
|
unprognostic (1.61e-3)
|
unprognostic (3.15e-3)
|
unprognostic (1.59e-1)
|
unprognostic (1.52e-2)
|
unprognostic (2.07e-1)
|
unprognostic (2.26e-2)
|
unprognostic (5.66e-2)
|
unprognostic (2.03e-2)
|
unprognostic (4.27e-2)
|
unprognostic (1.04e-1)
|
unprognostic (1.81e-1)
|
unprognostic (6.36e-2)
|
unprognostic (1.33e-1)
|
unprognostic (1.27e-2)
|
unprognostic (8.56e-3)
|
unprognostic (8.89e-3)
|
unprognostic (2.24e-1)
|
unprognostic (2.87e-2)
|
FUCA2
|
dJ20N2.5, MGC1314
|
ENSG00000001036
|
Alpha-L-fucosidase 2
|
Q9BTY2
|
6
|
143494812-143511720
|
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
| null |
Glycosidase, Hydrolase
| null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
parathyroid gland: 159.9
|
Low cell type specificity
|
Detected in many
| null | null |
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Skin - Fibroblast_2, Spleen - Macrophages, Thyroid gland - Thyroid glandular cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA031659, HPA031661
|
Approved
| null | null | null | null | null | null | null | null | null |
Cluster 38: Monocytes & Neutrophils - Degranulation
|
Cluster 24: Parathyroid gland - Vesicular transport
|
Cluster 50: Non-specific - Nucleic acid binding
|
Cluster 28: Non-specific - Nuclear processes
|
Cluster 77: Plasma cells - Protein processing
| 16
| null | null |
HPA031659: AB_10600661, HPA031661: AB_10601681
|
unprognostic (7.65e-2)
|
unprognostic (1.78e-3)
|
unprognostic (1.06e-2)
|
unprognostic (1.77e-2)
|
unprognostic (2.02e-2)
|
unprognostic (7.60e-3)
|
unprognostic (2.82e-2)
|
unprognostic (3.42e-4)
|
unprognostic (2.48e-2)
|
unprognostic (6.94e-3)
|
unprognostic (1.03e-4)
|
unprognostic (1.52e-1)
|
unprognostic (3.29e-2)
|
unprognostic (1.22e-10)
|
unprognostic (2.82e-8)
|
unprognostic (1.38e-5)
|
unprognostic (4.73e-2)
|
unprognostic (8.50e-2)
|
unprognostic (5.08e-3)
|
unprognostic (2.53e-3)
|
unprognostic (8.04e-2)
|
unprognostic (2.21e-1)
|
unprognostic (9.57e-2)
|
unprognostic (2.60e-1)
|
unprognostic (1.47e-1)
|
unprognostic (8.60e-3)
|
unprognostic (3.20e-1)
|
unprognostic (6.23e-2)
|
unprognostic (1.27e-1)
|
unprognostic (6.09e-2)
|
unprognostic (2.35e-2)
|
GCLC
|
GCS, GLCL, GLCLC
|
ENSG00000001084
|
Glutamate-cysteine ligase catalytic subunit
|
P48506
|
6
|
53497341-53616970
|
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
| null |
Ligase
|
Disease variant, Hereditary hemolytic anemia
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
liver: 147.6
|
Low cell type specificity
|
Detected in many
| null | null |
Low cell type specificity
|
Detected in all
| null | null |
Cancer enhanced
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Immune cell enhanced
|
Detected in many
| null |
NK-cell: 4.2
|
Low lineage specificity
|
Detected in many
| null | null |
Cancer enhanced
|
Detected in all
| null |
Gallbladder cancer: 429.9
|
Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Spleen - Macrophages
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
CAB009569, HPA036359, HPA036360
|
Approved
| null |
Approved
|
Nucleoplasm,Nucleoli,Cytosol
| null | null | null | null | null | null |
Cluster 41: Basophils - Unknown function
|
Cluster 83: Liver - Metabolism
|
Cluster 13: Oligodendrocytes - Mixed function
|
Cluster 7: Liver cancer - Metabolism
|
Cluster 12: Squamous epithelial cells - Keratinization
| 7
|
Nucleoplasm
|
Nucleoli, Cytosol
|
CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789
|
unprognostic (1.08e-1)
|
unprognostic (2.34e-2)
|
unprognostic (6.97e-2)
|
unprognostic (3.56e-3)
|
unprognostic (1.58e-1)
|
unprognostic (6.77e-2)
|
unprognostic (1.44e-1)
|
unprognostic (1.15e-1)
|
unprognostic (1.93e-1)
|
unprognostic (3.34e-2)
|
unprognostic (6.04e-8)
|
unprognostic (1.31e-3)
|
unprognostic (3.69e-3)
|
unprognostic (3.95e-1)
|
unprognostic (1.23e-1)
|
unprognostic (8.70e-4)
|
unprognostic (5.88e-2)
|
unprognostic (2.42e-1)
|
unprognostic (6.42e-2)
|
unprognostic (3.83e-1)
|
unprognostic (1.92e-1)
|
unprognostic (1.85e-1)
|
unprognostic (8.98e-2)
|
unprognostic (2.18e-2)
|
unprognostic (9.49e-4)
|
unprognostic (4.34e-1)
|
unprognostic (2.33e-3)
|
unprognostic (4.10e-1)
|
unprognostic (1.65e-1)
|
unprognostic (3.69e-2)
|
unprognostic (2.18e-1)
|
NFYA
|
CBF-B, HAP2, NF-YA
|
ENSG00000001167
|
Nuclear transcription factor Y subunit alpha
|
P23511
|
6
|
41072974-41102403
|
Predicted intracellular proteins, Transcription factors
| null |
Activator, DNA-binding
| null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in many
| null |
Early spermatids: 37.8;Late spermatids: 48.8
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Testis - Early spermatids
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
CAB009250, HPA050779
|
Enhanced
| null |
Supported
|
Nucleoplasm
| null | null | null | null | null | null |
Cluster 33: Non-specific - ATP binding
|
Cluster 40: Non-specific - Transcription
|
Cluster 11: White matter - Signal transduction
|
Cluster 28: Non-specific - Nuclear processes
|
Cluster 63: Late spermatids - Spermatogenesis
| 32
|
Nucleoplasm
| null |
CAB009250: AB_2152107, HPA050779: AB_2681234
|
unprognostic (8.42e-2)
|
unprognostic (2.79e-2)
|
unprognostic (2.71e-2)
|
unprognostic (4.04e-3)
|
unprognostic (4.07e-1)
|
unprognostic (1.42e-1)
|
unprognostic (4.75e-1)
|
unprognostic (2.37e-2)
|
unprognostic (3.49e-2)
|
unprognostic (5.15e-3)
|
unprognostic (5.08e-4)
|
unprognostic (7.41e-3)
|
unprognostic (3.83e-2)
|
unprognostic (1.68e-3)
|
unprognostic (1.39e-2)
|
unprognostic (1.83e-2)
|
unprognostic (7.19e-3)
|
unprognostic (3.32e-1)
|
unprognostic (8.77e-2)
|
unprognostic (2.18e-1)
|
unprognostic (1.05e-1)
|
unprognostic (3.61e-3)
|
unprognostic (1.13e-1)
|
unprognostic (3.23e-1)
|
unprognostic (9.49e-3)
|
unprognostic (1.59e-1)
|
unprognostic (3.51e-2)
|
unprognostic (3.57e-1)
|
unprognostic (1.46e-1)
|
unprognostic (3.53e-2)
|
unprognostic (6.11e-2)
|
STPG1
|
C1orf201, FLJ33340, MAPO2
|
ENSG00000001460
|
Sperm tail PG-rich repeat containing 1
|
Q5TH74
|
1
|
24356999-24416934
|
Predicted intracellular proteins
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
testis: 26.7
|
Group enriched
|
Detected in many
| 13
|
Early spermatids: 214.1;Late spermatids: 677.5
|
Cell type enhanced
|
Detected in all
| null |
ependymal cell: 101.0
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in some
| null | null |
Low lineage specificity
|
Detected in many
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids
|
Low region specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in many
| null | null |
HPA024301
| null | null |
Approved
|
Nucleoplasm
| null | null | null | null | null | null |
Cluster 12: Non-specific - Mitochondrial translation
|
Cluster 8: Ciliated cells - Cilium organization
|
Cluster 52: Neurons & Synapses - Synaptic function
|
Cluster 37: Non-specific - mRNA processing
|
Cluster 63: Late spermatids - Spermatogenesis
| null |
Nucleoplasm
| null |
HPA024301: AB_1845634
|
unprognostic (4.58e-2)
|
unprognostic (3.44e-1)
| null |
unprognostic (1.35e-1)
|
unprognostic (2.48e-2)
|
unprognostic (1.79e-1)
|
unprognostic (5.99e-5)
| null |
unprognostic (7.83e-3)
|
unprognostic (2.52e-2)
|
unprognostic (1.12e-8)
|
unprognostic (1.99e-2)
|
unprognostic (1.67e-2)
|
unprognostic (2.89e-3)
| null |
unprognostic (4.01e-3)
|
unprognostic (1.67e-1)
|
unprognostic (1.19e-2)
|
unprognostic (1.89e-1)
|
unprognostic (1.85e-1)
|
unprognostic (2.57e-1)
|
unprognostic (3.50e-1)
|
unprognostic (1.54e-1)
|
unprognostic (3.39e-2)
|
unprognostic (3.81e-2)
|
unprognostic (1.24e-1)
|
unprognostic (2.06e-1)
|
unprognostic (5.50e-2)
|
unprognostic (1.34e-1)
|
unprognostic (4.45e-1)
|
unprognostic (5.63e-2)
|
NIPAL3
|
DJ462O23.2, NPAL3, SLC57A5
|
ENSG00000001461
|
NIPA like domain containing 3
|
Q6P499
|
1
|
24415802-24472976
|
Predicted intracellular proteins, Predicted membrane proteins, Transporters
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
brain: 65.3
|
Cell type enhanced
|
Detected in all
| null |
Cone photoreceptor cells: 98.6;Oligodendrocytes: 85.5;Prostatic glandular cells: 192.0
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Adrenal gland - Adrenal cortex cells, Colon - Smooth muscle cells, Prostate - Prostate glandular cells, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA039978
|
Approved
| null |
Approved
|
Nucleoplasm
| null | null | null | null | null | null |
Cluster 5: Non-specific - Cell proliferation
|
Cluster 9: Oligodendrocytes - Myelination
|
Cluster 26: Oligodendrocytes - Mixed function
|
Cluster 64: Connective tissue cells - ECM organization
|
Cluster 40: Prostatic glandular cells - Transcription
| 8
|
Nucleoplasm
| null |
HPA039978: AB_10697712
|
unprognostic (2.29e-1)
|
unprognostic (1.46e-1)
|
unprognostic (6.19e-2)
|
unprognostic (2.88e-3)
|
unprognostic (1.76e-2)
|
unprognostic (1.03e-1)
|
unprognostic (6.52e-2)
|
unprognostic (2.43e-2)
|
unprognostic (7.61e-2)
|
unprognostic (1.99e-2)
|
unprognostic (1.35e-9)
|
unprognostic (3.24e-3)
|
unprognostic (1.25e-2)
|
unprognostic (8.50e-5)
|
unprognostic (1.15e-1)
|
unprognostic (6.18e-2)
|
unprognostic (1.10e-1)
|
unprognostic (2.17e-1)
|
unprognostic (3.41e-2)
|
unprognostic (9.12e-2)
|
unprognostic (7.92e-2)
|
unprognostic (6.60e-2)
|
unprognostic (1.08e-4)
|
unprognostic (2.17e-1)
|
unprognostic (8.50e-2)
|
unprognostic (4.05e-2)
|
unprognostic (3.85e-1)
|
unprognostic (3.08e-2)
|
unprognostic (1.82e-1)
|
unprognostic (2.38e-2)
|
unprognostic (1.61e-2)
|
LAS1L
|
FLJ12525, Las1
|
ENSG00000001497
|
LAS1 like ribosome biogenesis factor
|
Q9Y4W2
|
X
|
65438549-65534810
|
Disease related genes, Human disease related genes, Predicted intracellular proteins
| null |
Hydrolase
|
Disease variant, Intellectual disability, Obesity
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Late spermatids: 143.1
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Testis - Sertoli cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA044431, HPA061463
|
Supported
| null |
Uncertain
|
Nucleoplasm,Centriolar satellite,Cytosol
| null | null | null | null | null | null |
Cluster 13: Non-specific - Mitochondria
|
Cluster 66: Non-specific - Transcription
|
Cluster 13: Oligodendrocytes - Mixed function
|
Cluster 36: Non-specific - mRNA processing
|
Cluster 63: Late spermatids - Spermatogenesis
| 51
|
Nucleoplasm
|
Centriolar satellite, Cytosol
|
HPA044431: AB_10965695, HPA061463: AB_2684530
|
unprognostic (1.42e-1)
|
unprognostic (3.99e-3)
|
unprognostic (1.49e-1)
|
unprognostic (1.80e-3)
|
unprognostic (2.24e-1)
|
unprognostic (4.98e-2)
|
unprognostic (5.11e-1)
|
unprognostic (4.67e-3)
|
unprognostic (6.80e-3)
|
unprognostic (5.41e-2)
|
unprognostic (1.15e-3)
|
unprognostic (7.75e-2)
|
unprognostic (5.08e-2)
|
unprognostic (1.99e-2)
|
unprognostic (3.52e-4)
|
unprognostic (3.01e-2)
|
unprognostic (2.88e-3)
|
unprognostic (5.13e-2)
|
unprognostic (1.66e-1)
|
unprognostic (1.40e-1)
|
unprognostic (2.56e-2)
|
unprognostic (2.64e-2)
|
unprognostic (5.67e-3)
|
unprognostic (4.29e-2)
|
unprognostic (2.84e-1)
|
unprognostic (8.22e-2)
|
unprognostic (1.30e-1)
|
unprognostic (9.82e-2)
|
unprognostic (7.60e-4)
|
unprognostic (1.99e-2)
|
unprognostic (3.23e-2)
|
ENPP4
|
AP3Aase, KIAA0879, NPP4
|
ENSG00000001561
|
Ectonucleotide pyrophosphatase/phosphodiesterase 4
|
Q9Y6X5
|
6
|
46129989-46146688
|
Enzymes, Predicted membrane proteins
| null |
Hydrolase
| null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in many
| null |
Basal prostatic cells: 95.2;dendritic cells: 70.1;Oligodendrocytes: 116.7
|
Cell type enhanced
|
Detected in all
| null |
oligodendrocyte: 134.6
|
Low cancer specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in many
| null | null |
Low lineage specificity
|
Detected in many
| null | null |
Low cancer specificity
|
Detected in many
| null | null |
Breast - Endothelial cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA016594
|
Approved
| null | null | null | null | null | null | null | null | null |
Cluster 3: Non-specific - Nuclear processes
|
Cluster 9: Oligodendrocytes - Myelination
|
Cluster 28: Oligodendrocytes - Mixed function
|
Cluster 15: Kidney cancer - Membrane components
|
Cluster 3: Basal prostatic cells - Lipid metabolism
| 10
| null | null |
HPA016594: AB_1848171
|
unprognostic (5.85e-3)
|
unprognostic (3.15e-2)
|
unprognostic (1.14e-1)
|
unprognostic (2.42e-2)
|
unprognostic (4.22e-2)
|
unprognostic (6.22e-2)
|
unprognostic (3.13e-1)
|
unprognostic (3.85e-2)
|
unprognostic (1.48e-1)
|
unprognostic (1.79e-1)
|
unprognostic (9.35e-9)
|
unprognostic (7.29e-4)
|
unprognostic (6.11e-2)
|
unprognostic (9.29e-2)
|
unprognostic (7.56e-2)
|
unprognostic (6.89e-3)
|
unprognostic (4.05e-2)
|
unprognostic (3.49e-4)
|
unprognostic (2.75e-2)
|
unprognostic (1.77e-1)
|
unprognostic (3.70e-3)
|
unprognostic (3.08e-1)
|
unprognostic (2.22e-2)
|
unprognostic (2.51e-1)
|
unprognostic (1.08e-1)
|
unprognostic (3.08e-3)
| null |
unprognostic (1.05e-1)
|
unprognostic (1.99e-1)
|
unprognostic (3.58e-2)
|
unprognostic (1.19e-1)
|
SEMA3F
|
Sema4, SEMAK
|
ENSG00000001617
|
Semaphorin 3F
|
Q13275
|
3
|
50155045-50189075
|
Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
| null | null | null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at transcript level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
esophagus: 97.9
|
Cell type enhanced
|
Detected in many
| null |
Adipocytes: 38.2;Basal prostatic cells: 33.1;Bipolar cells: 23.9;Endothelial cells: 26.5;Suprabasal keratinocytes: 34.7
|
Cell type enhanced
|
Detected in many
| null |
endothelial cell: 28.8
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Not detected in immune cells
|
Not detected
| null | null |
Not detected
|
Not detected
| null | null |
Cancer enhanced
|
Detected in all
| null |
Gallbladder cancer: 84.1
|
Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Pituitary gland - Endothelial cells, Skin - Keratinocyte (other)
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in many
| null | null |
HPA035008
|
Approved
| null | null | null | null | null | null | null | null | null | null |
Cluster 27: Squamous epithelium - Keratinization
|
Cluster 38: Sub-cortical - Mixed function
|
Cluster 48: Adipocytes & Endothelial cells - Angiogenesis
|
Cluster 12: Squamous epithelial cells - Keratinization
| null | null | null |
HPA035008: AB_10604091
|
unprognostic (5.00e-2)
|
unprognostic (2.59e-1)
|
unprognostic (1.13e-1)
|
unprognostic (1.75e-1)
|
unprognostic (1.99e-1)
|
unprognostic (1.33e-2)
|
unprognostic (2.23e-3)
|
unprognostic (1.99e-2)
|
unprognostic (2.34e-1)
|
unprognostic (2.50e-1)
|
unprognostic (8.31e-7)
|
unprognostic (3.53e-3)
|
unprognostic (2.38e-1)
|
unprognostic (2.74e-4)
|
unprognostic (9.23e-3)
|
unprognostic (2.30e-2)
|
unprognostic (7.06e-3)
|
unprognostic (1.45e-1)
|
unprognostic (2.56e-1)
|
unprognostic (8.53e-2)
|
unprognostic (2.52e-1)
|
unprognostic (6.67e-3)
|
unprognostic (2.58e-1)
|
unprognostic (7.71e-2)
|
unprognostic (3.61e-2)
|
unprognostic (2.36e-1)
|
unprognostic (1.08e-1)
|
unprognostic (1.26e-1)
|
unprognostic (1.26e-1)
|
unprognostic (2.20e-2)
|
unprognostic (1.66e-1)
|
CFTR
|
ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR
|
ENSG00000001626
|
CF transmembrane conductance regulator
|
P13569
|
7
|
117287120-117715971
|
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
| null |
Chloride channel, Ion channel, Isomerase
|
Cancer-related genes, Disease variant, FDA approved drug targets
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in many
| null |
gallbladder: 48.4;intestine: 43.6;pancreas: 192.0
|
Group enriched
|
Detected in many
| 4
|
Ductal cells: 590.0;Late spermatids: 149.9
|
Cell type enhanced
|
Detected in many
| null |
oligodendrocyte: 247.2
|
Group enriched
|
Detected in many
| null | null |
Low region specificity
|
Detected in many
| null | null |
Not detected in immune cells
|
Not detected
| null | null |
Not detected
|
Not detected
| null | null |
Cancer enhanced
|
Detected in many
| null |
colorectal cancer: 24.2;Gastric cancer: 9.6
|
Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells
|
Low region specificity
|
Detected in single
| null | null |
Low region specificity
|
Detected in all
| null | null |
CAB001951, HPA021939, HPA079652
|
Enhanced
| null | null | null | null | null | null | null | null | null | null |
Cluster 15: Pancreas - Proteolysis
|
Cluster 11: White matter - Signal transduction
|
Cluster 57: Stomach & Colon cancer - Digestion
|
Cluster 45: Non-specific - Mixed function
| 372
| null | null |
CAB001951: , HPA021939: AB_1846578, HPA079652:
| null | null |
unprognostic (2.40e-1)
|
unprognostic (2.21e-1)
|
unprognostic (1.25e-2)
|
unprognostic (2.36e-4)
| null | null | null |
unprognostic (5.50e-3)
|
unprognostic (7.23e-3)
| null |
unprognostic (6.53e-2)
|
unprognostic (5.71e-2)
|
unprognostic (5.84e-2)
|
unprognostic (3.02e-4)
|
unprognostic (4.86e-1)
|
unprognostic (3.43e-2)
|
unprognostic (1.93e-1)
|
unprognostic (1.97e-1)
|
unprognostic (2.56e-2)
|
unprognostic (2.29e-2)
|
unprognostic (7.79e-2)
|
unprognostic (6.28e-2)
|
unprognostic (5.19e-3)
|
unprognostic (2.45e-1)
| null |
unprognostic (1.32e-1)
|
unprognostic (2.58e-1)
| null |
unprognostic (1.67e-3)
|
ANKIB1
|
DKFZP434A0225, KIAA1386
|
ENSG00000001629
|
Ankyrin repeat and IBR domain containing 1
|
Q9P2G1
|
7
|
92245974-92401383
|
Enzymes, Predicted intracellular proteins
| null |
Transferase
| null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Excitatory neurons: 176.4;Inhibitory neurons: 209.0;Oligodendrocyte precursor cells: 165.6;Oligodendrocytes: 549.9
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in many
| null | null |
Low lineage specificity
|
Detected in many
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Adrenal gland - Adrenal cortex cells, Testis - Spermatocytes
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA019358, HPA021780
|
Uncertain
| null |
Supported
|
Plasma membrane,Cytosol
| null | null | null | null | null | null |
Cluster 14: Non-specific - Unknown function
|
Cluster 61: Brain - Neuronal signaling
|
Cluster 13: Oligodendrocytes - Mixed function
|
Cluster 39: Non-specific - Transcription
|
Cluster 51: Oligodendrocytes - Unknown function
| 2
|
Plasma membrane, Cytosol
| null |
HPA019358: AB_1844831, HPA021780: AB_2670819
|
unprognostic (3.63e-2)
|
unprognostic (3.94e-2)
|
unprognostic (1.28e-1)
|
unprognostic (2.05e-3)
|
unprognostic (4.01e-1)
|
unprognostic (2.57e-1)
|
unprognostic (3.65e-1)
|
unprognostic (1.54e-1)
|
unprognostic (1.26e-1)
|
unprognostic (2.96e-6)
|
unprognostic (3.92e-6)
|
unprognostic (1.29e-1)
|
unprognostic (6.10e-2)
|
unprognostic (1.60e-4)
|
unprognostic (6.43e-2)
|
unprognostic (3.18e-2)
|
unprognostic (4.19e-2)
|
unprognostic (5.18e-2)
|
unprognostic (3.94e-1)
|
unprognostic (1.52e-1)
|
unprognostic (1.94e-2)
|
unprognostic (1.11e-3)
|
unprognostic (7.77e-2)
|
unprognostic (4.40e-2)
|
unprognostic (5.97e-3)
|
unprognostic (1.31e-1)
|
unprognostic (1.14e-1)
|
unprognostic (6.26e-3)
|
unprognostic (2.89e-1)
|
unprognostic (4.55e-2)
|
unprognostic (1.67e-1)
|
CYP51A1
|
CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1
|
ENSG00000001630
|
Cytochrome P450 family 51 subfamily A member 1
|
Q16850
|
7
|
92084987-92134803
|
Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
| null |
Monooxygenase, Oxidoreductase
|
FDA approved drug targets
|
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in all
| null |
liver: 196.0
|
Cell type enhanced
|
Detected in many
| null |
Early spermatids: 52.6;Kupffer cells: 56.0;Oligodendrocytes: 49.4;Squamous epithelial cells: 50.2
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Colon - Macrophages, Liver - Hepatocytes, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA041325, HPA043508
|
Approved
| null |
Approved
|
Endoplasmic reticulum
| null | null | null | null | null | null |
Cluster 13: Non-specific - Mitochondria
|
Cluster 69: Liver - Oxidoreductase activity
|
Cluster 49: Hindbrain - Mixed function
|
Cluster 57: Stomach & Colon cancer - Digestion
|
Cluster 62: Hepatocytes - Metabolism
| 12
|
Endoplasmic reticulum
| null |
HPA041325: AB_2677411, HPA043508: AB_2678520
|
unprognostic (2.56e-2)
|
unprognostic (1.94e-1)
|
unprognostic (9.05e-2)
|
unprognostic (2.32e-4)
|
unprognostic (2.91e-3)
|
unprognostic (1.54e-1)
|
unprognostic (1.62e-1)
|
unprognostic (1.64e-3)
|
unprognostic (7.22e-4)
|
unprognostic (7.26e-4)
|
unprognostic (2.27e-9)
|
unprognostic (6.45e-2)
|
unprognostic (3.14e-1)
|
unprognostic (1.25e-1)
|
unprognostic (6.25e-2)
|
unprognostic (3.93e-2)
|
unprognostic (2.40e-1)
|
unprognostic (2.27e-1)
|
unprognostic (2.67e-2)
|
unprognostic (3.09e-1)
|
unprognostic (2.54e-1)
|
unprognostic (1.12e-1)
|
unprognostic (5.56e-2)
|
unprognostic (3.83e-2)
|
unprognostic (6.86e-2)
|
unprognostic (1.05e-1)
|
unprognostic (1.49e-1)
|
unprognostic (1.14e-1)
|
unprognostic (3.85e-1)
|
unprognostic (4.24e-2)
|
unprognostic (4.72e-2)
|
KRIT1
|
CAM, CCM1
|
ENSG00000001631
|
KRIT1 ankyrin repeat containing
|
O00522
|
7
|
92197498-92246166
|
Disease related genes, Human disease related genes, Predicted intracellular proteins
| null | null |
Disease variant
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Inhibitory neurons: 88.8;Oligodendrocytes: 107.4
|
Low cell type specificity
|
Detected in many
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Testis - Spermatocytes
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA049606
|
Supported
| null |
Uncertain
|
Vesicles
| null | null | null | null | null | null |
Cluster 5: Non-specific - Cell proliferation
|
Cluster 51: Thyroid gland - Unknown function
|
Cluster 55: Non-specific - Transcription
|
Cluster 39: Non-specific - Transcription
|
Cluster 49: Non-specific - Transcription
| 13
|
Vesicles
| null |
HPA049606: AB_2680832
|
unprognostic (1.91e-1)
|
unprognostic (1.03e-1)
|
unprognostic (1.72e-2)
|
unprognostic (3.65e-2)
|
unprognostic (4.37e-2)
|
unprognostic (2.32e-2)
|
unprognostic (4.30e-1)
|
unprognostic (9.86e-3)
|
unprognostic (3.80e-2)
|
unprognostic (4.13e-4)
|
unprognostic (1.96e-6)
|
unprognostic (2.28e-3)
|
unprognostic (1.81e-1)
|
unprognostic (3.74e-3)
|
unprognostic (2.24e-1)
|
unprognostic (3.02e-1)
|
unprognostic (2.04e-1)
|
unprognostic (2.52e-2)
|
unprognostic (1.39e-1)
|
unprognostic (3.11e-2)
|
unprognostic (1.19e-1)
|
unprognostic (1.07e-1)
|
unprognostic (2.89e-1)
|
unprognostic (1.21e-1)
|
unprognostic (1.01e-2)
|
unprognostic (1.77e-1)
|
unprognostic (9.49e-2)
|
unprognostic (7.34e-2)
|
unprognostic (3.28e-1)
|
unprognostic (5.63e-2)
|
unprognostic (1.67e-1)
|
RAD52
| null |
ENSG00000002016
|
RAD52 homolog, DNA repair protein
|
P43351
|
12
|
911736-990053
|
Cancer-related genes, Predicted intracellular proteins
| null |
DNA-binding
|
Cancer-related genes
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Group enriched
|
Detected in many
| 4
|
Astrocytes: 33.1;Excitatory neurons: 36.7;Inhibitory neurons: 46.8;Microglial cells: 22.4;Oligodendrocyte precursor cells: 28.3;Oligodendrocytes: 50.8
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null | null |
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA028957
| null | null |
Approved
|
Nuclear speckles,Plasma membrane
| null | null | null | null | null | null |
Cluster 5: Non-specific - Cell proliferation
|
Cluster 19: Non-specific - Basic cellular processes
|
Cluster 11: White matter - Signal transduction
|
Cluster 38: Non-specific - Transcription
|
Cluster 8: Neurons - Neuronal signaling
| 23
|
Nuclear speckles
|
Plasma membrane
|
HPA028957: AB_2672842
|
unprognostic (1.35e-1)
|
unprognostic (5.29e-2)
|
unprognostic (3.23e-1)
|
unprognostic (1.72e-2)
|
unprognostic (1.69e-1)
|
unprognostic (1.18e-1)
|
unprognostic (4.94e-2)
|
unprognostic (9.70e-3)
|
unprognostic (1.75e-1)
|
unprognostic (6.18e-5)
|
unprognostic (3.05e-3)
|
unprognostic (3.09e-2)
|
unprognostic (2.70e-1)
|
unprognostic (2.01e-3)
|
unprognostic (3.94e-2)
|
unprognostic (1.39e-1)
|
unprognostic (7.56e-2)
|
unprognostic (2.53e-2)
|
unprognostic (1.27e-1)
|
unprognostic (1.01e-1)
|
unprognostic (6.98e-2)
|
unprognostic (4.41e-3)
|
unprognostic (1.81e-2)
|
unprognostic (3.51e-1)
|
unprognostic (9.94e-4)
|
unprognostic (3.91e-1)
|
unprognostic (1.00e-1)
|
unprognostic (5.35e-2)
|
unprognostic (5.06e-1)
|
unprognostic (8.91e-2)
|
unprognostic (1.89e-1)
|
BAD
|
BBC2, BCL2L8
|
ENSG00000002330
|
BCL2 associated agonist of cell death
|
Q92934
|
11
|
64269830-64284704
|
Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins
| null | null |
Cancer-related genes
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Low cell type specificity
|
Detected in all
| null | null |
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null | null |
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
CAB004205, HPA028185, HPA062105
|
Approved
| null |
Enhanced
|
Mitochondria,Mid piece,Principal piece,End piece
| null | null | null | null | null | null |
Cluster 29: Non-specific - Unknown function
|
Cluster 43: Non-specific - Mitochondrial translation
|
Cluster 27: Non-specific - Mixed function
|
Cluster 24: Non-specific - Unknown function
|
Cluster 5: Enterocytes - Absorption
| 44
|
Mitochondria
|
Mid piece, Principal piece, End piece
|
CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684
|
unprognostic (1.86e-1)
|
unprognostic (2.17e-1)
|
unprognostic (9.12e-3)
|
unprognostic (7.87e-2)
|
unprognostic (6.68e-2)
|
unprognostic (2.76e-1)
|
unprognostic (1.27e-1)
|
unprognostic (8.77e-2)
|
unprognostic (7.89e-2)
|
unprognostic (1.08e-2)
|
unprognostic (1.11e-1)
|
unprognostic (1.18e-2)
|
unprognostic (3.69e-2)
|
unprognostic (4.49e-4)
|
unprognostic (1.65e-1)
|
unprognostic (4.51e-2)
|
unprognostic (1.06e-1)
|
unprognostic (4.44e-2)
|
unprognostic (4.74e-1)
|
unprognostic (1.95e-1)
|
unprognostic (2.37e-1)
|
unprognostic (1.42e-1)
|
unprognostic (4.78e-4)
|
unprognostic (1.24e-1)
|
unprognostic (2.52e-1)
|
unprognostic (3.25e-1)
|
unprognostic (7.57e-2)
|
unprognostic (1.45e-1)
|
unprognostic (1.13e-1)
|
unprognostic (2.27e-1)
|
unprognostic (3.05e-1)
|
LAP3
|
LAP, LAPEP, PEPS
|
ENSG00000002549
|
Leucine aminopeptidase 3
|
P28838
|
4
|
17577198-17607972
|
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
| null |
Aminopeptidase, Hydrolase, Protease
| null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Hofbauer cells: 264.8;Proximal tubular cells: 263.7
|
Cell type enhanced
|
Detected in all
| null |
endothelial cell: 82.6
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null | null |
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA029606, HPA029607
|
Enhanced
| null |
Approved
|
Nucleoplasm,Midbody,Cytosol,Calyx,Mid piece,Principal piece
| null | null | null | null | null | null |
Cluster 10: Non-specific - Membrane trafficking
|
Cluster 70: Lymphoid tissue - Immune response
|
Cluster 19: Astrocytes - Mixed function
|
Cluster 31: Non-specific - Antiviral immune response
|
Cluster 41: Adipocytes & Endothelial cells - Mixed function
| 15
|
Cytosol
|
Nucleoplasm, Midbody, Calyx, Mid piece, Principal piece
|
HPA029606: AB_10599288, HPA029607: AB_10611381
|
unprognostic (6.83e-2)
|
unprognostic (3.01e-1)
|
unprognostic (1.42e-2)
|
unprognostic (8.58e-2)
|
unprognostic (3.35e-2)
|
unprognostic (1.19e-1)
|
unprognostic (7.13e-2)
|
unprognostic (2.42e-1)
|
unprognostic (3.03e-1)
|
unprognostic (2.79e-1)
|
unprognostic (6.48e-5)
|
unprognostic (2.87e-2)
|
unprognostic (1.31e-2)
|
unprognostic (7.91e-2)
|
unprognostic (8.29e-2)
|
unprognostic (5.58e-2)
|
unprognostic (3.31e-2)
|
unprognostic (1.04e-2)
|
unprognostic (3.46e-1)
|
unprognostic (1.11e-1)
|
unprognostic (4.17e-2)
|
unprognostic (1.08e-2)
|
unprognostic (1.24e-1)
|
unprognostic (2.11e-1)
|
unprognostic (8.87e-2)
|
unprognostic (5.10e-2)
|
unprognostic (4.00e-2)
|
unprognostic (9.97e-2)
|
unprognostic (5.68e-3)
|
unprognostic (3.55e-1)
|
unprognostic (4.35e-1)
|
CD99
|
MIC2
|
ENSG00000002586
|
CD99 molecule (Xg blood group)
|
P14209
|
X
|
2691187-2741309
|
CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Low cell type specificity
|
Detected in many
| null | null |
Cell type enhanced
|
Detected in some
| null |
ependymal cell: 6.5;leukocyte: 5.7;pericyte: 7.7
|
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Skin - Fibroblast_1, Skin - Fibroblast_2
| null | null | null | null |
Low region specificity
|
Detected in all
| null | null |
CAB000020, HPA035304
|
Supported
| null |
Approved
|
Golgi apparatus
| null | null | null | null | null | null |
Cluster 13: Non-specific - Mitochondria
|
Cluster 41: Smooth muscle tissue - ECM organization
|
Cluster 39: Astrocytes - Mixed function
|
Cluster 12: Bone cancer - Neuronal signaling
|
Cluster 53: Fibroblasts - ECM organization
| 3
|
Golgi apparatus
| null |
CAB000020: AB_2076419, HPA035304: AB_10672861
|
unprognostic (3.46e-1)
|
unprognostic (1.46e-2)
|
unprognostic (3.51e-2)
|
unprognostic (1.62e-1)
|
unprognostic (2.98e-2)
|
unprognostic (3.47e-2)
|
unprognostic (3.56e-2)
| null |
unprognostic (5.61e-2)
|
unprognostic (4.04e-2)
|
unprognostic (6.99e-2)
|
unprognostic (2.45e-1)
|
unprognostic (8.18e-2)
|
unprognostic (2.31e-3)
| null |
unprognostic (1.13e-4)
|
unprognostic (2.06e-4)
|
unprognostic (1.39e-1)
|
unprognostic (3.68e-2)
|
unprognostic (4.27e-1)
|
unprognostic (2.23e-1)
|
unprognostic (4.12e-2)
|
unprognostic (4.41e-3)
|
unprognostic (1.69e-1)
|
unprognostic (2.22e-1)
|
unprognostic (4.33e-2)
|
unprognostic (3.05e-2)
|
unprognostic (7.86e-3)
|
unprognostic (7.75e-2)
|
unprognostic (1.30e-2)
|
unprognostic (5.70e-2)
|
HS3ST1
|
3OST1
|
ENSG00000002587
|
Heparan sulfate-glucosamine 3-sulfotransferase 1
|
O14792
|
4
|
11393150-11429564
|
Enzymes, Metabolic proteins, Predicted intracellular proteins
| null |
Transferase
| null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in many
| null |
ovary: 30.9
|
Cell type enhanced
|
Detected in many
| null |
Granulosa cells: 147.6;Ionocytes: 127.4;Lymphatic endothelial cells: 98.3;Ovarian stromal cells: 172.3;Peritubular cells: 88.0
|
Cell type enhanced
|
Detected in many
| null |
upper rhombic lip: 122.7
|
Low cancer specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
Group enriched
|
Detected in some
| null |
memory B-cell: 15.0;naive B-cell: 26.7;plasmacytoid DC: 42.5
|
Group enriched
|
Detected in many
| 110
|
B-cells: 26.7;dendritic cells: 42.5
|
Cancer enhanced
|
Detected in many
| null |
pancreatic cancer: 29.8
|
Prostate - Endothelial cells
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA002237
|
Approved
| null |
Approved
|
Vesicles
| null | null | null | null | null | null |
Cluster 8: Plasmacytoid DCs - Unknown function
|
Cluster 64: Neuronal - Transcription
|
Cluster 35: Non-specific - DNA binding
|
Cluster 53: Squamous epithelial cells - Keratinization
|
Cluster 6: Ovarian stromal cells - Transcription
| 28
|
Vesicles
| null |
HPA002237: AB_1079085
|
unprognostic (1.63e-2)
|
unprognostic (1.88e-2)
|
unprognostic (7.69e-2)
|
unprognostic (1.77e-2)
|
unprognostic (3.47e-2)
|
unprognostic (2.20e-1)
|
unprognostic (1.05e-1)
|
unprognostic (2.44e-2)
|
unprognostic (1.47e-2)
|
unprognostic (1.52e-1)
|
unprognostic (6.69e-7)
|
unprognostic (2.72e-1)
|
unprognostic (6.60e-2)
| null |
unprognostic (6.06e-2)
|
unprognostic (1.78e-1)
|
unprognostic (4.93e-2)
|
unprognostic (8.28e-2)
|
unprognostic (2.75e-1)
|
unprognostic (3.49e-2)
|
unprognostic (5.31e-2)
|
unprognostic (3.83e-2)
|
unprognostic (2.37e-1)
|
unprognostic (6.00e-2)
|
unprognostic (4.33e-2)
|
unprognostic (7.61e-2)
|
unprognostic (1.90e-2)
|
unprognostic (1.62e-2)
|
unprognostic (1.86e-1)
|
unprognostic (7.93e-2)
|
unprognostic (1.00e-1)
|
AOC1
|
ABP, ABP1, DAO
|
ENSG00000002726
|
Amine oxidase copper containing 1
|
P19801
|
7
|
150824627-150861504
|
Enzymes, Metabolic proteins, Predicted secreted proteins
| null |
Heparin-binding, Oxidoreductase
| null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Group enriched
|
Detected in many
| null |
intestine: 221.1;kidney: 131.7;placenta: 479.6
|
Cell type enhanced
|
Detected in many
| null |
Collecting duct cells: 241.2;Distal enterocytes: 377.7;Intestinal goblet cells: 116.8;Paneth cells: 304.1;Proximal enterocytes: 876.3
|
Group enriched
|
Detected in some
| null |
ependymal cell: 3.5;midbrain-derived inhibitory: 2.6
|
Cancer enhanced
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
Immune cell enriched
|
Detected in some
| null |
eosinophil: 31.3
|
Lineage enriched
|
Detected in many
| 22
|
granulocytes: 31.3
|
Cancer enhanced
|
Detected in many
| null |
colorectal cancer: 48.4
|
Colon - Colon enterocytes
|
Not detected
|
Not detected
| null | null |
Not detected
|
Not detected
| null | null |
HPA031032, HPA031033
|
Approved
| null | null | null | null | null | null | null | null | null |
Cluster 36: Eosinophils - Protein ubiquitination
|
Cluster 45: Intestine - Digestion
|
Cluster 46: Brainstem - Mixed function
|
Cluster 57: Stomach & Colon cancer - Digestion
|
Cluster 5: Enterocytes - Absorption
| 8
| null | null |
HPA031032: AB_10670150, HPA031033: AB_10669670
|
unprognostic (2.72e-2)
|
unprognostic (2.10e-2)
| null |
unprognostic (7.24e-2)
|
unprognostic (1.10e-2)
|
unprognostic (1.33e-1)
| null | null |
unprognostic (3.32e-2)
|
unprognostic (6.01e-2)
|
unprognostic (1.36e-6)
|
unprognostic (1.03e-3)
|
unprognostic (1.03e-2)
|
unprognostic (4.78e-3)
| null |
unprognostic (1.06e-1)
|
unprognostic (2.23e-1)
|
unprognostic (2.76e-3)
|
unprognostic (1.00e-1)
|
unprognostic (2.30e-1)
|
unprognostic (2.66e-2)
|
unprognostic (1.10e-1)
|
unprognostic (4.03e-3)
|
unprognostic (7.64e-3)
|
unprognostic (3.12e-2)
|
unprognostic (5.26e-3)
| null |
unprognostic (9.01e-2)
|
unprognostic (2.71e-2)
|
unprognostic (2.02e-1)
|
unprognostic (1.01e-3)
|
WNT16
| null |
ENSG00000002745
|
Wnt family member 16
|
Q9UBV4
|
7
|
121325367-121341104
|
Predicted intracellular proteins, Predicted secreted proteins
| null |
Developmental protein
| null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at transcript level
|
Evidence at protein level
|
Group enriched
|
Detected in some
| null |
cervix: 5.8;skin 1: 20.0
|
Cell type enhanced
|
Detected in some
| null |
B-cells: 3.8;Basal keratinocytes: 6.0;Endometrial stromal cells: 3.3;Inhibitory neurons: 5.8;Microglial cells: 3.6;Suprabasal keratinocytes: 6.3
|
Group enriched
|
Detected in some
| null |
ependymal cell: 9.1;fibroblast: 18.1;LAMP5-LHX6 and Chandelier: 9.4;MGE interneuron: 23.1
|
Low cancer specificity
|
Detected in some
| null | null |
Low region specificity
|
Detected in many
| null | null |
Group enriched
|
Detected in some
| null |
memory B-cell: 15.6;naive B-cell: 15.5
|
Lineage enriched
|
Detected in single
| 146
|
B-cells: 15.6
|
Cancer enhanced
|
Detected in many
| null |
Leukemia: 9.8
|
Colon - Enteric glia cells, Spleen - B-cells (Spleen)
|
Low region specificity
|
Detected in single
| null | null |
Low region specificity
|
Detected in all
| null | null | null | null | null | null | null | null | null | null | null | null | null |
Cluster 23: B-cells - Immunoglobulins
|
Cluster 13: Skin - Cornification
|
Cluster 23: Choroid plexus - Mixed function
|
Cluster 6: Leukemia - Signal transduction
|
Cluster 8: Neurons - Neuronal signaling
| null | null | null | null | null | null |
unprognostic (8.22e-2)
| null | null | null |
unprognostic (1.42e-3)
| null | null | null | null | null | null | null | null |
unprognostic (5.54e-3)
| null |
unprognostic (3.03e-1)
| null | null | null | null | null | null | null | null | null | null | null | null | null |
HECW1
|
KIAA0322, NEDL1
|
ENSG00000002746
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
|
Q76N89
|
7
|
43112629-43566001
|
Enzymes, Metabolic proteins, Predicted intracellular proteins
| null |
Transferase
| null |
Evidence at protein level
|
Evidence at transcript level
|
Evidence at protein level
|
Evidence at protein level
|
Tissue enhanced
|
Detected in some
| null |
brain: 8.0;kidney: 7.5
|
Cell type enhanced
|
Detected in some
| null |
Early spermatids: 131.2;Excitatory neurons: 515.5;Inhibitory neurons: 151.1;Late spermatids: 78.2;Oligodendrocyte precursor cells: 260.8
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in many
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in some
| null | null |
Low lineage specificity
|
Detected in single
| null | null |
Low cancer specificity
|
Detected in many
| null | null |
Breast - Fibroblasts, Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA007203, HPA007593, HPA007609
|
Uncertain
| null |
Approved
|
Nucleoli fibrillar center,Cytosol
| null | null | null | null | null | null |
Cluster 20: Non-specific - DNA binding
|
Cluster 61: Brain - Neuronal signaling
|
Cluster 14: Neurons - Synaptic function
|
Cluster 7: Liver cancer - Metabolism
|
Cluster 34: Neurons - Neuronal signaling
| 6
|
Nucleoli fibrillar center
|
Cytosol
|
HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518
|
unprognostic (8.99e-2)
| null |
unprognostic (2.98e-1)
|
unprognostic (6.83e-4)
|
unprognostic (1.19e-3)
|
unprognostic (3.57e-2)
|
unprognostic (2.50e-1)
| null |
unprognostic (1.61e-1)
| null |
unprognostic (2.77e-3)
| null |
unprognostic (3.26e-2)
| null | null |
unprognostic (1.26e-1)
| null |
unprognostic (2.83e-1)
| null | null | null |
unprognostic (5.45e-2)
|
unprognostic (7.64e-2)
|
unprognostic (2.72e-1)
| null |
unprognostic (2.24e-2)
| null |
unprognostic (1.66e-1)
|
unprognostic (3.31e-1)
| null |
unprognostic (1.97e-2)
|
MAD1L1
|
HsMAD1, MAD1, PIG9, TP53I9, TXBP181
|
ENSG00000002822
|
Mitotic arrest deficient 1 like 1
|
Q9Y6D9
|
7
|
1815793-2233243
|
Disease related genes, Human disease related genes, Predicted intracellular proteins
| null | null |
Disease variant
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in many
| null |
Early spermatids: 28.1;Excitatory neurons: 20.2;Inhibitory neurons: 23.3;Late spermatids: 59.1;Microglial cells: 20.6;Oligodendrocytes: 30.2
|
Low cell type specificity
|
Detected in all
| null | null |
Cancer enhanced
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Testis - Early spermatids, Testis - Late spermatids
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA003635, CAB015338
|
Supported
| null |
Supported
|
Nucleoplasm,Nuclear membrane
| null | null | null | null | null | null |
Cluster 9: T-regs - Cell cycle regulation
|
Cluster 70: Lymphoid tissue - Immune response
|
Cluster 11: White matter - Signal transduction
|
Cluster 67: Non-specific - Unknown function
|
Cluster 7: T-cells - T-cell receptor
| 61
|
Nucleoplasm, Nuclear membrane
| null |
CAB015338: AB_627901, HPA003635: AB_1853472
|
unprognostic (1.28e-1)
|
unprognostic (1.64e-1)
|
unprognostic (2.37e-1)
|
unprognostic (3.34e-1)
|
unprognostic (1.85e-2)
|
unprognostic (7.03e-2)
|
unprognostic (1.08e-1)
|
unprognostic (1.97e-2)
|
unprognostic (5.34e-2)
|
unprognostic (1.44e-1)
|
unprognostic (3.78e-2)
|
unprognostic (1.01e-1)
|
unprognostic (8.39e-4)
|
unprognostic (1.86e-4)
|
unprognostic (3.70e-2)
|
unprognostic (2.46e-2)
|
unprognostic (4.94e-2)
|
unprognostic (9.24e-2)
|
unprognostic (1.46e-1)
|
unprognostic (2.21e-3)
|
unprognostic (1.05e-1)
|
unprognostic (1.61e-1)
|
unprognostic (5.09e-4)
|
unprognostic (7.47e-2)
|
unprognostic (1.61e-1)
|
unprognostic (6.41e-2)
|
unprognostic (3.20e-2)
|
unprognostic (2.03e-1)
|
unprognostic (2.36e-2)
|
unprognostic (1.14e-1)
|
unprognostic (3.76e-1)
|
LASP1
|
Lasp-1, MLN50
|
ENSG00000002834
|
LIM and SH3 protein 1
|
Q14847
|
17
|
38869859-38921770
|
Cancer-related genes, Plasma proteins, Predicted intracellular proteins
| null |
Actin-binding
|
Cancer-related genes
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Late spermatids: 588.6;Proximal enterocytes: 277.0
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Spleen - Fibroblast_1
|
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA012072, CAB022049
|
Enhanced
| null |
Supported
|
Plasma membrane,Focal adhesion sites,Cytosol
| null | null | null | null | null | null |
Cluster 38: Monocytes & Neutrophils - Degranulation
|
Cluster 25: Small intestine - Absorption
|
Cluster 38: Sub-cortical - Mixed function
|
Cluster 27: Breast cancer - Unknown function
|
Cluster 36: Late spermatids - Unknown function
| 35
|
Plasma membrane, Cytosol
|
Focal adhesion sites
|
CAB022049: , HPA012072: AB_1852714
|
unprognostic (8.07e-2)
|
unprognostic (3.35e-1)
|
unprognostic (5.77e-2)
|
unprognostic (9.20e-4)
|
unprognostic (3.18e-1)
|
unprognostic (1.48e-1)
|
unprognostic (2.52e-1)
|
unprognostic (8.20e-2)
|
unprognostic (1.49e-1)
|
unprognostic (4.68e-2)
|
unprognostic (5.01e-5)
|
unprognostic (9.04e-2)
|
unprognostic (3.62e-1)
|
unprognostic (8.54e-4)
|
unprognostic (9.46e-3)
|
unprognostic (2.53e-4)
|
unprognostic (9.54e-3)
|
unprognostic (8.17e-3)
|
unprognostic (2.25e-1)
|
unprognostic (2.63e-2)
|
unprognostic (1.46e-1)
|
unprognostic (4.16e-2)
|
unprognostic (1.19e-1)
|
unprognostic (1.41e-1)
|
unprognostic (6.40e-2)
|
unprognostic (1.49e-1)
|
unprognostic (6.83e-2)
|
unprognostic (1.60e-2)
|
unprognostic (2.68e-1)
|
unprognostic (3.98e-2)
|
unprognostic (2.26e-1)
|
SNX11
| null |
ENSG00000002919
|
Sorting nexin 11
|
Q9Y5W9
|
17
|
48103357-48123601
|
Predicted intracellular proteins
| null | null | null |
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Evidence at protein level
|
Low tissue specificity
|
Detected in all
| null | null |
Cell type enhanced
|
Detected in all
| null |
Oocytes: 36.0
|
Low cell type specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
Low immune cell specificity
|
Detected in all
| null | null |
Low lineage specificity
|
Detected in all
| null | null |
Low cancer specificity
|
Detected in all
| null | null | null |
Low region specificity
|
Detected in all
| null | null |
Low region specificity
|
Detected in all
| null | null |
HPA044787, HPA054660
|
Approved
| null |
Approved
|
Endoplasmic reticulum,Vesicles
| null | null | null | null | null | null |
Cluster 28: Neutrophils - Unknown function
|
Cluster 70: Lymphoid tissue - Immune response
|
Cluster 13: Oligodendrocytes - Mixed function
|
Cluster 55: Lymphoma - Immune response
|
Cluster 14: Langerhans cells - Innate immune response
| 10
|
Endoplasmic reticulum
|
Vesicles
|
HPA044787: AB_10795988, HPA054660: AB_2682560
|
unprognostic (8.83e-2)
|
unprognostic (7.86e-3)
|
unprognostic (2.35e-1)
|
unprognostic (9.77e-2)
|
unprognostic (4.46e-2)
|
unprognostic (1.01e-2)
|
unprognostic (9.13e-2)
|
unprognostic (6.92e-3)
|
unprognostic (9.92e-2)
|
unprognostic (7.29e-2)
|
unprognostic (3.06e-5)
|
unprognostic (4.02e-2)
|
unprognostic (5.99e-4)
|
unprognostic (2.27e-4)
|
unprognostic (2.62e-3)
|
unprognostic (3.47e-1)
|
unprognostic (1.67e-1)
|
unprognostic (4.76e-2)
|
unprognostic (2.08e-1)
|
unprognostic (5.54e-2)
|
unprognostic (6.57e-3)
|
unprognostic (1.31e-1)
|
unprognostic (3.67e-2)
|
unprognostic (2.52e-1)
|
unprognostic (1.46e-2)
|
unprognostic (1.73e-1)
|
unprognostic (2.08e-1)
|
unprognostic (2.21e-1)
|
unprognostic (1.63e-1)
|
unprognostic (1.37e-1)
|
unprognostic (1.13e-1)
|
End of preview.
No dataset card yet
- Downloads last month
- -